Corticobasal degeneration (CBD): treatment
Evidence-based neurology checklist on corticobasal degeneration (cbd): treatment: Levodopa Levodopa/carbidopa therapeutic trial is started at 62.5mg tid The dose is increased to 125mg tid 1g daily dose is needed for adequate trial Treatments of myoclonus Treatments of cognitive impairment…
Levodopa
- Levodopa/carbidopa therapeutic trial is started at 62.5mg tid
- The dose is increased to 125mg tid
- 1g daily dose is needed for adequate trial
Treatments of myoclonus
Treatments of cognitive impairment
Treatments of depression and OCD
Other treatments
References
- Armstrong MJ. Diagnosis and treatment of corticobasal degeneration. Curr Treat Options Neurol 2014; 16:282.
- Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47:1-9.
